Membrane protein research services using synthetic copolymers
Cube Biotech is a contract research organization specializing in membrane protein characterization and structure determination. Their tech stack is overwhelmingly operational (Excel, Power BI, Sage ERP, Microsoft 365, VMware) with no biotech-specific tools visible — a signal that they're scaling internal processes and supply-chain infrastructure rather than building software products. Active hiring is concentrated in operations, marketing, and finance, paired with projects around ERP implementation, supply-chain optimization, and digitalization, indicating a transition from a pure-services model toward more repeatable, process-driven delivery.
Cube Biotech, founded in 2012 and based in Monheim, Germany, is a contract research organization that serves industrial and academic partners in drug discovery. Their core offering is membrane protein research using a proprietary synthetic copolymer portfolio — an alternative to traditional detergents for native protein characterization. The company provides services across protein preparation, biophysical target characterization, cryo-EM structure determination, and assay development, with flexible engagement models including FTE, fee-for-service, and milestone-based arrangements. Current workforce is 51–200 employees, with active hiring in operations, marketing, and finance roles.
Membrane protein research and contract services for drug discovery, including protein characterization, structure determination by cryo-EM, assay development, and a proprietary synthetic copolymer portfolio for native protein stabilization.
Monheim, Germany. The company was founded in 2012 and is privately held.
Other companies in the same industry, closest in size